<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Meunier, Danièle</dc:creator>
  <dc:creator>Findlay, Jacqueline</dc:creator>
  <dc:creator>Doumith, Michel</dc:creator>
  <dc:creator>Godoy, Daniel</dc:creator>
  <dc:creator>Perry, Claire</dc:creator>
  <dc:creator>Pike, Rachel</dc:creator>
  <dc:creator>Gronthoud, Firza</dc:creator>
  <dc:creator>Shryane, Theresa</dc:creator>
  <dc:creator>Poirel, Laurent</dc:creator>
  <dc:creator>Welfare, William</dc:creator>
  <dc:creator>Woodford, Neil</dc:creator>
  <dc:creator>Hopkins, Katie L.</dc:creator>
  <dc:date>2017-09-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Objectives: Detection of rarer carbapenemases is challenging, as it requires molecular  assays with comprehensive coverage or the use of phenotypic methods for the  detection of carbapenemase activity. We describe a new class A carbapenemase,  FRI-2, in an Enterobacter cloacae complex isolate following implementation of an in-  house multiplex PCR for the detection of ‘rare’ class A carbapenemases.Methods:  MICs were determined by agar dilution. A carbapenem-resistant E. cloacae complex  isolate was tested by PCR for the class A carbapenemases blaKPC, blaFRI, blaIMI,  blaGES and blaSME. Carbapenemase activity was assessed using Carba NP and the  carbapenem inactivation method. Whole genome and plasmid analyses of the clinical  isolate and the FRI-2 transformant were performed by WGS, respectively. Typing was  carried out by PFGE.Results: The E. cloacae complex isolate showed resistance to  imipenem (MIC = 16 mg/L), meropenem (MIC = 8 mg/L) and ertapenem (MIC = 8   mg/L), but remained susceptible to piperacillin/tazobactam (MIC = 8 mg/L).  Carbapenemase activity was confirmed in the isolate by both phenotypic methods. A  blaFRI-1-like gene was detected by PCR and analysis of WGS data of the clinical  isolate identified an ORF of 885 bp, which showed 97% nucleotide identity with  blaFRI-1 and was named blaFRI-2. WGS of the transformant indicated blaFRI-2 was  located on a 108 kb IncF/IncR plasmid. The FRI-2-positive E. cloacae complex isolate  belonged to a novel ST (ST829).ConclusionsThe possible circulation of rarer  carbapenemases in clinical settings highlights the role of phenotypic tests to detect  carbapenemase activity when molecular assays are negative for the ‘big 5’  carbapenemase families.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/306130</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/306130/files/poi_fcp.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1093/jac/dkx173</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Journal of Antimicrobial Chemotherapy. - 2017, vol. 72, no. 9, p. 2478–2482</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">FRI-2 carbapenemase-producing Enterobacter cloacae complex in the UK</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
